1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet 2020; 395: 2008-2020.
3. Zhang J, He J, Zhang L. The down-regulation of microRNA-137 contributes to the up-regulation of retinoblastoma cell proliferation and invasion by regulating COX-2/PGE2 signaling. Biomed Pharmacother 2018; 106: 35-42.
4. Otto T, Candido SV, Pilarz MS et al. Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit. Proc Natl Acad Sci U S A 2017; 114: 10660-10665.
5. Zhu L, Xue F, Xu X et al. MicroRNA-198 inhibition of HGF/c-MET signaling pathway overcomes resistance to radiotherapy and induces apoptosis in human non-small-cell lung cancer. J Cell Biochem 2018; 119: 7873-7886.
6. Alidadiani N, Ghaderi S, Dilaver N et al. Epithelial mesenchymal transition Transcription Factor (TF): The structure, function and microRNA feedback loop. Gene 2018; 674: 115-120.
7. Zhang Z, Pan B, Lv S et al. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data. Cell Physiol Biochem 2018; 49: 678-695.
8. Zhang C, Xie L, Fu Y et al. lncRNA MIAT promotes esophageal squamous cell carcinoma progression by regulating miR-1301-3p/INCENP axis and interacting with SOX2. J Cell Physiol 2020; 235: 7933-7944.
9. Wen J, Wang H, Dong T et al. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway. Cell Prolif 2019; 52: e12569.
10. Wang X, Hu K, Chao Y, Wang L. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis. Biomed Pharmacother 2019; 114: 108798.
11. Luo D, Fan H, Ma X et al. miR-1301-3p Promotes Cell Proliferation and Facilitates Cell Cycle Progression via Targeting SIRT1 in Gastric Cancer. Front Oncol 2021; 11: 664242.
12. Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 2012; 16: 284-287.
13. Itoh K, Yoshioka K, Akedo H et al. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999; 5: 221-225.
14. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002; 2: 133-142.
15. Fujimura K, Choi S, Wyse M et al. Eukaryotic Translation Initiation Factor 5A (EIF5A) Regulates Pancreatic Cancer Metastasis by Modulating RhoA and Rho-associated Kinase (ROCK) Protein Expression Levels. J Biol Chem 2015; 290: 29907-29919.
16. Zimmerman NP, Roy I, Hauser AD et al. Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells. Mol Carcinog 2015; 54: 203-215.
17. Takiguchi S, Inoue K, Matsusue K et al. Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer. Int J Oncol 2017; 51: 184-192.
18. Das V, Bhattacharya S, Chikkaputtaiah C et al. The basics of epithelial-mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective. J Cell Physiol 2019.
19. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
20. Canel M, Serrels A, Frame MC, Brunton VG. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci 2013; 126: 393-401.
21. Labernadie A, Kato T, Brugues A et al. A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat Cell Biol 2017; 19: 224-237.
22. Richardson AM, Havel LS, Koyen AE et al. Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective Invasion. Clin Cancer Res 2018; 24: 420-432.
23. Padmanaban V, Krol I, Suhail Y et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature 2019; 573: 439-444.
24. Xu Z, Gu C, Yao X et al. CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer. Cell Death Dis 2020; 11: 202.
25. Zhu P, Yu H, Zhou K et al. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE2 pathway. J Exp Clin Cancer Res 2020; 39: 113.
26. Fan XD, Luo Y, Wang J, An N. miR-154-3p and miR-487-3p synergistically modulate RHOA signaling in the carcinogenesis of thyroid cancer. Biosci Rep 2020; 40.
27. Chandra Mangalhara K, Manvati S, Saini SK et al. ERK2-ZEB1-miR-101-1 axis contributes to epithelial-mesenchymal transition and cell migration in cancer. Cancer Lett 2017; 391: 59-73.